< BACK TO NEWS
positiveSYS.SOURCE: TechCrunch2026-09-23T19:31:28Z

Enveda Raises $311 Million for AI-Driven Natural Compound Drug Development

Enveda, a biotech startup leveraging AI to discover drugs from natural sources, secured $311 million in Series E funding at a $2 billion valuation. The company is advancing AI-discovered candidates into clinical trials, including treatments for skin conditions and weight loss management.

The round valued the AI biotech at $2 billion. It is currently testing drugs that treat skin conditions and preserve weight loss after stopping GLP-1s.

Read original article

*** END OF TRANSMISSION ***